A novel biochemical analysis for ApoE4 quantification in plasma and discrimination of homozygous and heterozygous APOE ε4 carriers
Abstract Background The APOE ε4 allele is the strongest genetic risk factor for late-onset Alzheimer’s disease (AD) and is associated with increased risk of amyloid-related imaging abnormalities (ARIA) during anti-amyloid therapy. Accurate identification of ε4 carriers, particularly APOE ε4/ε4 indiv...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2025-07-01
|
| Серии: | Alzheimer’s Research & Therapy |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s13195-025-01811-w |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|